With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had come to rely on compounded versions is increasingly uncertain.

A lawyer for the Trump administration couldn’t say whether the data DOGE accessed had been shared outside the US Treasury Department.